Investing.com -- Gilead Sciences Inc. announced Monday it has entered into a definitive agreement to acquire Ouro Medicines, a privately held biotechnology company focused on developing T cell engager ...

Gilead Sciences plans to acquire Ouro Medicines, a developer of autoimmune-disease therapies, for up to about $2.18 billion. Under the terms of the deal, Gilead would buy all of the outstanding equity ...

Artis BioSolutions, an advanced therapies company in San Diego, established new synthetic DNA manufacturing capabilities in Boston utilizing Bilbao, Spain-based Syngoi Technologies’ proprietary ...

Katherine Haan, MBA, is a Senior Staff Writer for Forbes Advisor and a former financial advisor turned international bestselling author and business coach. For more than a decade, she’s helped small ...

This is read by an automated voice. Please report any issues or inconsistencies here. Peter Jackson, the visionary filmmaker who adapted author J.R.R. Tolkien’s epic fantasy for the big screen in the ...

LUCKNOW: With Uttar Pradesh set to emerge as a global skill hub, the Yogi Adityanath government has been striving for the last nine years to bring about significant transformation in the fields of ...

Early drafts of the screenplay struggled with how to depict Woodward and Bernstein Sitting at a table in the sunroom of his Georgetown home, Woodward glances through Goldman’s 161-page script, ...

The city is rolling out a new plan to improve the Hub, an area that's most commonly known for drug use and distribution. The Third Avenue Business Improvement District is teaming up with the ...

The £13m transformation of a disused area of land in the city which is set to create a thriving business hub is gathering pace, with the first buildings topping-out this month (March). Did you know ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

Add Yahoo as a preferred source to see more of our stories on Google. Stephen Colbert said he was initially worried he wouldn't be able to balance the new "LOTR" film and his late-night series, "but ...